232 related articles for article (PubMed ID: 37506213)
1. Control of protein synthesis through mRNA pseudouridylation by dyskerin.
Pederiva C; Trevisan DM; Peirasmaki D; Chen S; Savage SA; Larsson O; Ule J; Baranello L; Agostini F; Farnebo M
Sci Adv; 2023 Jul; 9(30):eadg1805. PubMed ID: 37506213
[TBL] [Abstract][Full Text] [Related]
2. Dyskerin: an essential pseudouridine synthase with multifaceted roles in ribosome biogenesis, splicing, and telomere maintenance.
Garus A; Autexier C
RNA; 2021 Dec; 27(12):1441-1458. PubMed ID: 34556550
[TBL] [Abstract][Full Text] [Related]
3. Human ribosomes from cells with reduced dyskerin levels are intrinsically altered in translation.
Penzo M; Rocchi L; Brugiere S; Carnicelli D; Onofrillo C; Couté Y; Brigotti M; Montanaro L
FASEB J; 2015 Aug; 29(8):3472-82. PubMed ID: 25934701
[TBL] [Abstract][Full Text] [Related]
4. Severity of X-linked dyskeratosis congenita (DKCX) cellular defects is not directly related to dyskerin (DKC1) activity in ribosomal RNA biogenesis or mRNA translation.
Thumati NR; Zeng XL; Au HH; Jang CJ; Jan E; Wong JM
Hum Mutat; 2013 Dec; 34(12):1698-707. PubMed ID: 24115260
[TBL] [Abstract][Full Text] [Related]
5. Pseudouridylation defect due to
Balogh E; Chandler JC; Varga M; Tahoun M; Menyhárd DK; Schay G; Goncalves T; Hamar R; Légrádi R; Szekeres Á; Gribouval O; Kleta R; Stanescu H; Bockenhauer D; Kerti A; Williams H; Kinsler V; Di WL; Curtis D; Kolatsi-Joannou M; Hammid H; Szőcs A; Perczel K; Maka E; Toldi G; Sava F; Arrondel C; Kardos M; Fintha A; Hossain A; D'Arco F; Kaliakatsos M; Koeglmeier J; Mifsud W; Moosajee M; Faro A; Jávorszky E; Rudas G; Saied MH; Marzouk S; Kelen K; Götze J; Reusz G; Tulassay T; Dragon F; Mollet G; Motameny S; Thiele H; Dorval G; Nürnberg P; Perczel A; Szabó AJ; Long DA; Tomita K; Antignac C; Waters AM; Tory K
Proc Natl Acad Sci U S A; 2020 Jun; 117(26):15137-15147. PubMed ID: 32554502
[TBL] [Abstract][Full Text] [Related]
6. Mouse dyskerin mutations affect accumulation of telomerase RNA and small nucleolar RNA, telomerase activity, and ribosomal RNA processing.
Mochizuki Y; He J; Kulkarni S; Bessler M; Mason PJ
Proc Natl Acad Sci U S A; 2004 Jul; 101(29):10756-61. PubMed ID: 15240872
[TBL] [Abstract][Full Text] [Related]
7. Dyskerin and cancer: more than telomerase. The defect in mRNA translation helps in explaining how a proliferative defect leads to cancer.
Montanaro L
J Pathol; 2010 Dec; 222(4):345-9. PubMed ID: 20925138
[TBL] [Abstract][Full Text] [Related]
8. Impaired Telomere Maintenance and Decreased Canonical WNT Signaling but Normal Ribosome Biogenesis in Induced Pluripotent Stem Cells from X-Linked Dyskeratosis Congenita Patients.
Gu BW; Apicella M; Mills J; Fan JM; Reeves DA; French D; Podsakoff GM; Bessler M; Mason PJ
PLoS One; 2015; 10(5):e0127414. PubMed ID: 25992652
[TBL] [Abstract][Full Text] [Related]
9. Human dyskerin: beyond telomeres.
Angrisani A; Vicidomini R; Turano M; Furia M
Biol Chem; 2014 Jun; 395(6):593-610. PubMed ID: 24468621
[TBL] [Abstract][Full Text] [Related]
10. X-linked dyskeratosis congenita is predominantly caused by missense mutations in the DKC1 gene.
Knight SW; Heiss NS; Vulliamy TJ; Greschner S; Stavrides G; Pai GS; Lestringant G; Varma N; Mason PJ; Dokal I; Poustka A
Am J Hum Genet; 1999 Jul; 65(1):50-8. PubMed ID: 10364516
[TBL] [Abstract][Full Text] [Related]
11. Dyskerin Mutations Present in Dyskeratosis Congenita Patients Increase Oxidative Stress and DNA Damage Signalling in
Rodriguez-Centeno J; Perona R; Sastre L
Cells; 2019 Nov; 8(11):. PubMed ID: 31717312
[TBL] [Abstract][Full Text] [Related]
12. Novel dyskerin-mediated mechanism of p53 inactivation through defective mRNA translation.
Montanaro L; Calienni M; Bertoni S; Rocchi L; Sansone P; Storci G; Santini D; Ceccarelli C; Taffurelli M; Carnicelli D; Brigotti M; Bonafè M; Treré D; Derenzini M
Cancer Res; 2010 Jun; 70(11):4767-77. PubMed ID: 20501855
[TBL] [Abstract][Full Text] [Related]
13. Transcriptome-wide mapping reveals widespread dynamic-regulated pseudouridylation of ncRNA and mRNA.
Schwartz S; Bernstein DA; Mumbach MR; Jovanovic M; Herbst RH; León-Ricardo BX; Engreitz JM; Guttman M; Satija R; Lander ES; Fink G; Regev A
Cell; 2014 Sep; 159(1):148-162. PubMed ID: 25219674
[TBL] [Abstract][Full Text] [Related]
14. Human dyskerin binds to cytoplasmic H/ACA-box-containing transcripts affecting nuclear hormone receptor dependence.
Zacchini F; Venturi G; De Sanctis V; Bertorelli R; Ceccarelli C; Santini D; Taffurelli M; Penzo M; Treré D; Inga A; Dassi E; Montanaro L
Genome Biol; 2022 Aug; 23(1):177. PubMed ID: 35996163
[TBL] [Abstract][Full Text] [Related]
15. Crystal structure of a Cbf5-Nop10-Gar1 complex and implications in RNA-guided pseudouridylation and dyskeratosis congenita.
Rashid R; Liang B; Baker DL; Youssef OA; He Y; Phipps K; Terns RM; Terns MP; Li H
Mol Cell; 2006 Jan; 21(2):249-60. PubMed ID: 16427014
[TBL] [Abstract][Full Text] [Related]
16. A new human dyskerin isoform with cytoplasmic localization.
Angrisani A; Turano M; Paparo L; Di Mauro C; Furia M
Biochim Biophys Acta; 2011 Dec; 1810(12):1361-8. PubMed ID: 21820037
[TBL] [Abstract][Full Text] [Related]
17. Anomalous electrophoretic migration of newly synthesized ribosomal RNAs and their precursors from cells with DKC1 mutations.
Gu BW; Zhao C; Fan JM; Dai Q; Bessler M; Mason PJ
FEBS Lett; 2009 Sep; 583(18):3086-90. PubMed ID: 19729012
[TBL] [Abstract][Full Text] [Related]
18. Transcriptome-wide mapping of pseudouridines: pseudouridine synthases modify specific mRNAs in S. cerevisiae.
Lovejoy AF; Riordan DP; Brown PO
PLoS One; 2014; 9(10):e110799. PubMed ID: 25353621
[TBL] [Abstract][Full Text] [Related]
19. N-terminal residues of human dyskerin are required for interactions with telomerase RNA that prevent RNA degradation.
MacNeil DE; Lambert-Lanteigne P; Autexier C
Nucleic Acids Res; 2019 Jun; 47(10):5368-5380. PubMed ID: 30931479
[TBL] [Abstract][Full Text] [Related]
20. Dyskerin localizes to the nucleolus and its mislocalization is unlikely to play a role in the pathogenesis of dyskeratosis congenita.
Heiss NS; Girod A; Salowsky R; Wiemann S; Pepperkok R; Poustka A
Hum Mol Genet; 1999 Dec; 8(13):2515-24. PubMed ID: 10556300
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
